Search Results

Spineology Inc., the leader in ultra-minimally invasive spine surgery, announced that John Booth will retire from his role as Chief Executive Officer of Spineology, effective November 10, 2023.

Spineology Inc., the leader in ultra-minimally invasive spine surgery, announced the addition of Amanda Bloom as Executive Vice President, Marketing.

Spineology ® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales.

Spineology Inc., the leader in ultra-minimally invasive spine surgery, is proud to announce a transformative rebranding initiative that positions the company at the forefront of innovation in spine care.

Spineology Inc. , the longtime leader in ultra-minimally invasive spine surgery, today announced the appointment of Jamison Young to the position of Chief Financial Officer.

Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces the promotion of Matt Cronin to Chief Commercial Officer.

Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces another milestone today with the limited launch of OptiLIF® Endo.

We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system

Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).

Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).